Healthcare Services Group, Inc. (HCSG)
USD 9.37
(-1.58%)
USD 9.37
(-1.58%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 346.56 Million USD | 18.62% |
| 2022 | 292.16 Million USD | -10.06% |
| 2021 | 324.85 Million USD | 6.66% |
| 2020 | 304.57 Million USD | 16.12% |
| 2019 | 262.28 Million USD | 4.16% |
| 2018 | 251.82 Million USD | -8.78% |
| 2017 | 276.05 Million USD | 45.59% |
| 2016 | 189.6 Million USD | 2.77% |
| 2015 | 184.49 Million USD | -4.78% |
| 2014 | 193.74 Million USD | 38.2% |
| 2013 | 140.19 Million USD | 37.97% |
| 2012 | 101.61 Million USD | 41.19% |
| 2011 | 71.96 Million USD | 10.97% |
| 2010 | 64.85 Million USD | 13.55% |
| 2009 | 57.11 Million USD | 21.84% |
| 2008 | 46.87 Million USD | -3.64% |
| 2007 | 48.65 Million USD | -2.85% |
| 2006 | 50.07 Million USD | 24.37% |
| 2005 | 40.26 Million USD | 13.42% |
| 2004 | 35.5 Million USD | -4.38% |
| 2003 | 37.12 Million USD | 40.56% |
| 2002 | 26.41 Million USD | 20.91% |
| 2001 | 21.84 Million USD | 24.57% |
| 2000 | 17.53 Million USD | 46.15% |
| 1999 | 12 Million USD | -6.98% |
| 1998 | 12.9 Million USD | 1.57% |
| 1997 | 12.7 Million USD | 10.43% |
| 1996 | 11.5 Million USD | -2.54% |
| 1995 | 11.8 Million USD | -13.87% |
| 1994 | 13.7 Million USD | -1.44% |
| 1993 | 13.9 Million USD | 28.7% |
| 1992 | 10.8 Million USD | -23.94% |
| 1991 | 14.2 Million USD | 178.43% |
| 1990 | 5.1 Million USD | -57.5% |
| 1989 | 12 Million USD | -9.77% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 317.09 Million USD | -3.41% |
| 2024 Q1 | 329.29 Million USD | -4.98% |
| 2024 Q2 | 328.27 Million USD | -0.31% |
| 2023 Q3 | 308.98 Million USD | -0.7% |
| 2023 Q2 | 311.16 Million USD | 11.71% |
| 2023 Q1 | 278.56 Million USD | -4.66% |
| 2023 FY | 346.56 Million USD | 18.62% |
| 2023 Q4 | 346.56 Million USD | 12.16% |
| 2022 FY | 292.16 Million USD | -10.06% |
| 2022 Q1 | 299.87 Million USD | -7.69% |
| 2022 Q2 | 302.21 Million USD | 0.78% |
| 2022 Q3 | 300.08 Million USD | -0.7% |
| 2022 Q4 | 292.16 Million USD | -2.64% |
| 2021 FY | 324.85 Million USD | 6.66% |
| 2021 Q4 | 324.85 Million USD | 3.65% |
| 2021 Q3 | 313.4 Million USD | -4.94% |
| 2021 Q1 | 289.7 Million USD | -4.88% |
| 2021 Q2 | 329.69 Million USD | 13.8% |
| 2020 Q2 | 287 Million USD | -2.35% |
| 2020 FY | 304.57 Million USD | 16.12% |
| 2020 Q4 | 304.57 Million USD | 5.18% |
| 2020 Q3 | 289.58 Million USD | 0.9% |
| 2020 Q1 | 293.89 Million USD | 12.05% |
| 2019 FY | 262.28 Million USD | 4.16% |
| 2019 Q4 | 262.28 Million USD | -3.24% |
| 2019 Q3 | 271.06 Million USD | 4.06% |
| 2019 Q2 | 260.48 Million USD | -7.09% |
| 2019 Q1 | 280.37 Million USD | 11.34% |
| 2018 Q2 | 262.74 Million USD | -1.4% |
| 2018 Q1 | 266.46 Million USD | -3.47% |
| 2018 FY | 251.82 Million USD | -8.78% |
| 2018 Q4 | 251.82 Million USD | -6.17% |
| 2018 Q3 | 268.39 Million USD | 2.15% |
| 2017 Q3 | 271.08 Million USD | 13.11% |
| 2017 Q2 | 239.66 Million USD | 14.88% |
| 2017 FY | 276.05 Million USD | 45.59% |
| 2017 Q1 | 208.63 Million USD | 10.04% |
| 2017 Q4 | 276.05 Million USD | 1.83% |
| 2016 Q3 | 205.71 Million USD | 2.95% |
| 2016 FY | 189.6 Million USD | 2.77% |
| 2016 Q1 | 190.14 Million USD | 3.06% |
| 2016 Q4 | 189.6 Million USD | -7.83% |
| 2016 Q2 | 199.81 Million USD | 5.09% |
| 2015 Q4 | 184.49 Million USD | 3.83% |
| 2015 Q3 | 177.68 Million USD | -9.28% |
| 2015 Q2 | 195.85 Million USD | 10.54% |
| 2015 Q1 | 177.17 Million USD | -8.55% |
| 2015 FY | 184.49 Million USD | -4.78% |
| 2014 FY | 193.74 Million USD | 38.2% |
| 2014 Q4 | 193.74 Million USD | 11.78% |
| 2014 Q3 | 173.32 Million USD | 24.37% |
| 2014 Q2 | 139.37 Million USD | -5.41% |
| 2014 Q1 | 147.34 Million USD | 5.1% |
| 2013 Q3 | 111.34 Million USD | -0.49% |
| 2013 Q4 | 140.19 Million USD | 25.92% |
| 2013 FY | 140.19 Million USD | 37.97% |
| 2013 Q1 | 92.16 Million USD | -9.3% |
| 2013 Q2 | 111.89 Million USD | 21.4% |
| 2012 Q2 | 90.36 Million USD | 19.95% |
| 2012 Q3 | 88.31 Million USD | -2.27% |
| 2012 Q4 | 101.61 Million USD | 15.05% |
| 2012 FY | 101.61 Million USD | 41.19% |
| 2012 Q1 | 75.33 Million USD | 4.68% |
| 2011 Q1 | 60.69 Million USD | -6.42% |
| 2011 Q2 | 64.64 Million USD | 6.51% |
| 2011 Q3 | 56.21 Million USD | -13.04% |
| 2011 FY | 71.96 Million USD | 10.97% |
| 2011 Q4 | 71.96 Million USD | 28.02% |
| 2010 Q3 | 51.12 Million USD | -9.34% |
| 2010 Q2 | 56.39 Million USD | 20.81% |
| 2010 Q1 | 46.68 Million USD | -18.27% |
| 2010 Q4 | 64.85 Million USD | 26.85% |
| 2010 FY | 64.85 Million USD | 13.55% |
| 2009 Q2 | 50.41 Million USD | -10.64% |
| 2009 Q1 | 56.41 Million USD | 20.34% |
| 2009 FY | 57.11 Million USD | 21.84% |
| 2009 Q4 | 57.11 Million USD | -8.34% |
| 2009 Q3 | 62.31 Million USD | 23.61% |
| 2008 Q1 | 50.56 Million USD | 3.94% |
| 2008 Q4 | 46.87 Million USD | -14.48% |
| 2008 Q2 | 45.84 Million USD | -9.34% |
| 2008 Q3 | 54.81 Million USD | 19.58% |
| 2008 FY | 46.87 Million USD | -3.64% |
| 2007 FY | 48.65 Million USD | -2.85% |
| 2007 Q4 | 48.65 Million USD | -10.79% |
| 2007 Q3 | 54.53 Million USD | 21.31% |
| 2007 Q2 | 44.95 Million USD | -15.71% |
| 2007 Q1 | 53.33 Million USD | 6.51% |
| 2006 FY | 50.07 Million USD | 24.37% |
| 2006 Q4 | 50.07 Million USD | -4.24% |
| 2006 Q2 | 41.34 Million USD | -11.66% |
| 2006 Q1 | 46.8 Million USD | 16.22% |
| 2006 Q3 | 52.29 Million USD | 26.49% |
| 2005 Q1 | 42.68 Million USD | 20.21% |
| 2005 FY | 40.26 Million USD | 13.42% |
| 2005 Q2 | 36.61 Million USD | -14.22% |
| 2005 Q3 | 45.38 Million USD | 23.95% |
| 2005 Q4 | 40.26 Million USD | -11.27% |
| 2004 FY | 35.5 Million USD | -4.38% |
| 2004 Q2 | 41.92 Million USD | 21.81% |
| 2004 Q4 | 35.5 Million USD | -3.22% |
| 2004 Q3 | 36.68 Million USD | -12.5% |
| 2004 Q1 | 34.42 Million USD | -7.3% |
| 2003 Q4 | 37.12 Million USD | 32.34% |
| 2003 Q3 | 28.05 Million USD | -6.51% |
| 2003 Q2 | 30.01 Million USD | 22.58% |
| 2003 Q1 | 24.48 Million USD | -7.32% |
| 2003 FY | 37.12 Million USD | 40.56% |
| 2002 Q3 | 20.74 Million USD | -7.33% |
| 2002 Q4 | 26.41 Million USD | 27.3% |
| 2002 FY | 26.41 Million USD | 20.91% |
| 2002 Q1 | 18.26 Million USD | -16.42% |
| 2002 Q2 | 22.39 Million USD | 22.63% |
| 2001 Q1 | 12.86 Million USD | -26.62% |
| 2001 FY | 21.84 Million USD | 24.57% |
| 2001 Q4 | 21.84 Million USD | 40.65% |
| 2001 Q3 | 15.53 Million USD | -9.13% |
| 2001 Q2 | 17.09 Million USD | 32.82% |
| 2000 Q4 | 17.53 Million USD | 44.29% |
| 2000 FY | 17.53 Million USD | 46.15% |
| 2000 Q1 | 10.29 Million USD | -14.17% |
| 2000 Q2 | 14.91 Million USD | 44.81% |
| 2000 Q3 | 12.15 Million USD | -18.51% |
| 1999 Q1 | 14.6 Million USD | 13.18% |
| 1999 Q2 | 10.3 Million USD | -29.45% |
| 1999 FY | 12 Million USD | -6.98% |
| 1999 Q3 | 7.9 Million USD | -23.3% |
| 1999 Q4 | 12 Million USD | 51.9% |
| 1998 FY | 12.9 Million USD | 1.57% |
| 1998 Q4 | 12.9 Million USD | -16.77% |
| 1998 Q3 | 15.5 Million USD | 20.16% |
| 1998 Q2 | 12.9 Million USD | -7.86% |
| 1998 Q1 | 14 Million USD | 10.24% |
| 1997 Q3 | 15.5 Million USD | 12.32% |
| 1997 Q1 | 12.8 Million USD | 11.3% |
| 1997 FY | 12.7 Million USD | 10.43% |
| 1997 Q2 | 13.8 Million USD | 7.81% |
| 1997 Q4 | 12.7 Million USD | -18.06% |
| 1996 Q1 | 12.4 Million USD | 5.08% |
| 1996 Q4 | 11.5 Million USD | -19.58% |
| 1996 FY | 11.5 Million USD | -2.54% |
| 1996 Q3 | 14.3 Million USD | 22.22% |
| 1996 Q2 | 11.7 Million USD | -5.65% |
| 1995 Q2 | 10.9 Million USD | -16.15% |
| 1995 Q4 | 11.8 Million USD | -4.07% |
| 1995 Q3 | 12.3 Million USD | 12.84% |
| 1995 Q1 | 13 Million USD | -5.11% |
| 1995 FY | 11.8 Million USD | -13.87% |
| 1994 FY | 13.7 Million USD | -1.44% |
| 1994 Q2 | 12.4 Million USD | -12.06% |
| 1994 Q3 | 15.7 Million USD | 26.61% |
| 1994 Q4 | 13.7 Million USD | -12.74% |
| 1994 Q1 | 14.1 Million USD | 1.44% |
| 1993 Q2 | 11.3 Million USD | 17.71% |
| 1993 Q1 | 9.6 Million USD | -11.11% |
| 1993 Q3 | 10.7 Million USD | -5.31% |
| 1993 Q4 | 13.9 Million USD | 29.91% |
| 1993 FY | 13.9 Million USD | 28.7% |
| 1992 Q2 | 13.2 Million USD | -3.65% |
| 1992 FY | 10.8 Million USD | -23.94% |
| 1992 Q1 | 13.7 Million USD | -3.52% |
| 1992 Q4 | 10.8 Million USD | -23.4% |
| 1992 Q3 | 14.1 Million USD | 6.82% |
| 1991 Q2 | 3.6 Million USD | -12.2% |
| 1991 FY | 14.2 Million USD | 178.43% |
| 1991 Q4 | 14.2 Million USD | 425.93% |
| 1991 Q3 | 2.7 Million USD | -25.0% |
| 1991 Q1 | 4.1 Million USD | -19.61% |
| 1990 Q4 | 5.1 Million USD | 64.52% |
| 1990 Q2 | 3.5 Million USD | -72.22% |
| 1990 Q1 | 12.6 Million USD | 5.0% |
| 1990 Q3 | 3.1 Million USD | -11.43% |
| 1990 FY | 5.1 Million USD | -57.5% |
| 1989 FY | 12 Million USD | -9.77% |
| 1989 Q4 | 12 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 2.47 Billion USD | 85.976% |
| Addus HomeCare Corporation | 317.73 Million USD | -9.075% |
| AirSculpt Technologies, Inc. | 129.56 Million USD | -167.495% |
| Amedisys, Inc. | 940.38 Million USD | 63.146% |
| American Oncology Network, Inc. | 368.72 Million USD | 6.01% |
| Astrana Health, Inc. | 522.59 Million USD | 33.683% |
| Aveanna Healthcare Holdings Inc. | 1.76 Billion USD | 80.36% |
| IMAC Holdings, Inc. | 1.89 Million USD | -18171.416% |
| biote Corp. | 191.84 Million USD | -80.653% |
| Cryo-Cell International, Inc. | 72.25 Million USD | -379.663% |
| Cross Country Healthcare, Inc. | 205.92 Million USD | -68.298% |
| COMPASS Pathways plc | 50.24 Million USD | -589.78% |
| DocGo Inc. | 185.28 Million USD | -87.049% |
| The Ensign Group, Inc. | 2.68 Billion USD | 87.07% |
| InnovAge Holding Corp. | 247.85 Million USD | -39.827% |
| Assure Holdings Corp. | 22.84 Million USD | -1416.767% |
| The Joint Corp. | 62.37 Million USD | -455.581% |
| LifeStance Health Group, Inc. | 804.27 Million USD | 56.91% |
| Mobile-health Network Solutions Class A Ordinary Shares | 3.81 Million USD | -8993.447% |
| ModivCare Inc. | 1.61 Billion USD | 78.489% |
| NewGenIvf Group Limited | 1.24 Million USD | -27816.564% |
| Novo Integrated Sciences, Inc. | 11.06 Million USD | -3032.383% |
| Option Care Health, Inc. | 1.9 Billion USD | 81.824% |
| P3 Health Partners Inc. | 427.3 Million USD | 18.895% |
| P3 Health Partners Inc. | 427.3 Million USD | 18.895% |
| The Pennant Group, Inc. | 394.17 Million USD | 12.078% |
| Surgery Partners, Inc. | 3.65 Billion USD | 90.524% |
| Syra Health Corp. Class A Common Stock | 910.07 Thousand USD | -37981.163% |
| Talkspace, Inc. | 23.57 Million USD | -1370.057% |
| Talkspace, Inc. | 23.57 Million USD | -1370.057% |
| The Oncology Institute, Inc. | 162.39 Million USD | -113.412% |
| The Oncology Institute, Inc. | 162.39 Million USD | -113.412% |